COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,889 Articles (22,568 medRxiv, 8,321 bioRxiv)

Most recent first Previous |  Page 2781: Articles 27801-27810  | Next

Multiple expression assessments of ACE2 and TMPRSS2 SARS-CoV-2 entry molecules in the urinary tract and their associations with clinical manifestations of COVID-19
Ren, X., Wei, X., Li, G., Ren, S., Chen, X., Zhang, T., Zhang, X., Lu, Z., You, Z., Wang, S., Qin, C., Song, N., Wang, Z.
10.1101/2020.05.08.083618 — Posted: 2020-05-08
A potent neutralizing human antibody reveals the N-terminal domain of the Spike protein of SARS-CoV-2 as a site of vulnerability
Chi, X., Yan, R., Zhang, J., Zhang, G., Zhang, Y., Hao, M., Zhang, Z., Fan, P., Dong, Y., Yang, Y., Chen, Z., Guo, Y., Zhang, J., Li, Y., Song, X., Chen, Y., Xia, L., Fu, L., Hou, L., Xu, J., Yu, C., Li, J., Zhou, Q., Chen, W.
10.1101/2020.05.08.083964 — Posted: 2020-05-08
Efficacy of a novel iodine complex solution, CupriDyne, in inactivating SARS-CoV-2
Mantlo, E. K., Evans, A., Patterson-Fortin, L., Boutros, J., Smith, R., Paessler, S.
10.1101/2020.05.08.082701 — Posted: 2020-05-08 Discussion: Onsite
A structured open dataset of government interventions in response to COVID-19
Desvars-Larrive, A., Dervic, E., Haug, N., Niederkrotenthaler, T., Chen, J., Di Natale, A., Lasser, J., Gliga, D. S., Roux, A., Chakraborty, A., Ten, A., Dervic, A., Pacheco, A., Cserjan, D., Lederhilger, D., Berishaj, D., Flores Tames, E., Takriti, H., Korbel, J., Reddish, J., Stangl, J., Hadziavdic, L., Stoeger, L., Gooriah, L., Geyrhofer, L., Ferreira, M. R., Vierlinger, R., Holder, S., Alvarez, S., Haberfellner, S., Ahne, V., Reisch, V., Servedio, V. D., Chen, X., Pocasangre-Orellana, X. M., Garcia, D., Thurner, S.
10.1101/2020.05.04.20090498 — Posted: 2020-05-08
Covid-19 Pandemic in relation to levels of Pollution with PM2.5 and Ambient Salinity. An Environmental Wake-up Call
Muscat Baron, Y.
10.1101/2020.05.03.20087056 — Posted: 2020-05-08
Hydroxychloroquine and azithromycin plus zinc vs hydroxychloroquine and azithromycin alone: outcomes in hospitalized COVID-19 patients
Carlucci, P., Ahuja, T., Petrilli, C. M., Rajagopalan, H., Jones, S., Rahimian, J.
10.1101/2020.05.02.20080036 — Posted: 2020-05-08 Discussion: Onsite
The Impact of Coronavirus Disease 2019 (COVID-19) on Liver Injury in China: A Systematic Review and Meta-analysis
Zhao, X., Lei, Z.
10.1101/2020.05.03.20089557 — Posted: 2020-05-08
Acceptability of app-based contact tracing for COVID-19: Cross-country survey evidence
Altmann, S., Milsom, L., Zillessen, H., Blasone, R., Gerdon, F., Bach, R., Kreuter, F., Nosenzo, D., Toussaert, S., Abeler, J.
10.1101/2020.05.05.20091587 — Posted: 2020-05-08 Discussion: Offsite
COVID- 19 Infection in Children: Estimating Pediatric Morbidity and Mortality
Barton Forbes, M., Mehta, K., Kumar, K., Lu, J., Le Saux, N., Sampson, M., Robinson, J.
10.1101/2020.05.05.20091751 — Posted: 2020-05-08
Evolution of COVID-19 pandemic: Power law growth and saturation
Chatterjee, S., Shayak, B., Asad, A., Bhattacharya, S., Alam, S., Verma, M. K.
10.1101/2020.05.05.20091389 — Posted: 2020-05-08

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).